Financhill
Back

Trevi Therapeutics Stock Price Chart

  • The current trend is moderately bearish and TRVI is experiencing selling pressure, which indicates risk of future bearish movement.

Trevi Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 6.45 Buy
20-day SMA: 6.56 Sell
50-day SMA: 6.34 Buy
200-day SMA: 4.15 Buy
8-day EMA: 6.47 Buy
20-day EMA: 6.44 Buy
50-day EMA: 6.07 Buy
200-day EMA: 4.55 Buy

Trevi Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.09 Buy
Relative Strength Index (14 RSI): 52.34 Buy
Chaikin Money Flow: -618787 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.18 - 6.74) Buy
Bollinger Bands (100): (4.1 - 6.38) Buy

Trevi Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Trevi Therapeutics Stock

Is Trevi Therapeutics Stock a Buy?

TRVI Technical Analysis vs Fundamental Analysis

Buy
63
Trevi Therapeutics (TRVI) is a Buy

Is Trevi Therapeutics a Buy or a Sell?

Trevi Therapeutics Stock Info

Market Cap:
658.3M
Price in USD:
6.47
Share Volume:
999.6K

Trevi Therapeutics 52-Week Range

52-Week High:
7.39
52-Week Low:
2.30
Buy
63
Trevi Therapeutics (TRVI) is a Buy

Trevi Therapeutics Share Price Forecast

Is Trevi Therapeutics Stock a Buy?

  • Trevi Therapeutics share price is 6.47 while TRVI 8-day exponential moving average is 6.47, which is a Buy signal.
  • The stock price of TRVI is 6.47 while Trevi Therapeutics 20-day EMA is 6.44, which makes it a Buy.
  • Trevi Therapeutics 50-day exponential moving average is 6.07 while TRVI share price is 6.47, making it a Buy technically.
  • TRVI stock price is 6.47 and Trevi Therapeutics 200-day simple moving average is 4.55, creating a Buy signal.

Fundamental Analysis of Trevi Therapeutics

Is Trevi Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.07 per share.

Technical Analysis of Trevi Therapeutics

Should I short Trevi Therapeutics stock?

* Trevi Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.